CD8A and ovarian cancer: An overexpression of LAG-3 on tumor-infiltrating CD8+ T cells in different tumor types has also been reported for ovarian cancer, hepatocellular carcinoma, gastric cancer, and follicular lymphoma [51,52,53,54].